Canada markets open in 3 hours 29 minutes

Ascentage Pharma Group International (36X.F)

Frankfurt - Frankfurt Delayed Price. Currency in EUR
Add to watchlist
2.1800+0.0400 (+1.87%)
As of 09:59AM CEST. Market open.
Currency in EUR

Valuation Measures4

Market Cap (intraday) 648.68M
Enterprise Value 742.26M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)21.12
Price/Book (mrq)79.78
Enterprise Value/Revenue 3.34
Enterprise Value/EBITDA -1.00

Trading Information

Stock Price History

Beta (5Y Monthly) 1.18
52-Week Change 3-15.70%
S&P500 52-Week Change 321.33%
52 Week High 33.1800
52 Week Low 31.8600
50-Day Moving Average 32.4354
200-Day Moving Average 32.6885

Share Statistics

Avg Vol (3 month) 342
Avg Vol (10 day) 3N/A
Shares Outstanding 5290.2M
Implied Shares Outstanding 6303.12M
Float 8224.32M
% Held by Insiders 126.64%
% Held by Institutions 18.70%
Shares Short 4N/A
Short Ratio 4N/A
Short % of Float 4N/A
Short % of Shares Outstanding 4N/A
Shares Short (prior month ) 4N/A

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in CNY.

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-671.10%

Management Effectiveness

Return on Assets (ttm)-20.92%
Return on Equity (ttm)-386.28%

Income Statement

Revenue (ttm)221.98M
Revenue Per Share (ttm)0.79
Quarterly Revenue Growth (yoy)-30.40%
Gross Profit (ttm)N/A
EBITDA -812.82M
Net Income Avi to Common (ttm)-925.64M
Diluted EPS (ttm)-0.4200
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)1.1B
Total Cash Per Share (mrq)3.79
Total Debt (mrq)1.8B
Total Debt/Equity (mrq)2,542.18%
Current Ratio (mrq)1.44
Book Value Per Share (mrq)0.21

Cash Flow Statement

Operating Cash Flow (ttm)-726.08M
Levered Free Cash Flow (ttm)-706.12M